Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 12, 2024Frontiers in ImmunologyOpen Access

Plasma metabolites as mediators in immune cell-pancreatic cancer risk: insights from Mendelian randomization

View Full Paper
Ask AI
Bookmark
Share

Authors

KZKe ZhangDalian Medical UniversityJZJie ZhuBotho UniversityPWPeng WangGuangzhou University of Chinese Medicine

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhang et al. (2024) studied this question.

synapsesocial.com/papers/68e64f8fb6db6435875e0846https://doi.org/10.3389/fimmu.2024.1402113
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition2017 · 85 citations
  2. 2HMDB 4.0: the human metabolome database for 20182017 · 3,640 citations